Both in Pharmaceuticals
NewAmsterdam Pharma Company N.V vs Biohaven
Over the past year NAMS returned −46.2% and BHVN returned +5.1%; their daily moves had a correlation of 0.25.
NAMS −46.2% BHVN +5.1%Growth of $1, one year, split-adjusted
| Metric | NAMS | BHVN |
|---|---|---|
| Price | $19.90 | $15.61 |
| Market cap | $2.38B | $2.36B |
| Today | +1.74% | +2.97% |
| 1 month | −12.7% | +20.4% |
| 6 months | −33.3% | +60.8% |
| Year to date | −43.3% | +38.3% |
| 1 year | −47.6% | −9.2% |
| Revenue growth (YoY) | −80.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −1732.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 334.1× | — |
| Net cash | $633.9M | -$103.2M |
| Dividend yield | — | — |
| Volatility (60d) | 51.2% | 91.0% |
| Short % of float | 16.4% | 14.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).